Status:
COMPLETED
Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR)
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Collaborating Sponsors:
Barcelona Institute for Global Health
Conditions:
Covid19
Acute Respiratory Failure
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 pneumonia can cause severe acute hypoxemic respiratory failure. The usefulness of noninvasive respiratory support (NIRS), by means of nasal high-flow oxygen (NHFO), continuous positive airway...
Detailed Description
Multicenter, retrospective, longitudinal study in consecutive adult COVID-19 patients with acute respiratory failure, requiring noninvasive respiratory support (NIRS) outside the intensive care unit (...
Eligibility Criteria
Inclusion
- COVID-19 pneumonia confirmed with polymerase chain reaction (PCR).
- Acute respiratory failure.
- Treated by noninvasive respiratory support (nasal high-flow oxygen, CPAP or noninvasive ventilation), initiated outside the intensive care unit.
- Age \> 18 years
Exclusion
- Acute respiratory failure not related to COVID-19
- Hypercapnic acute respiratory failure
- Early intolerance to treatment
- Nosocomial infection
- Pregnant woman
Key Trial Info
Start Date :
May 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 25 2021
Estimated Enrollment :
367 Patients enrolled
Trial Details
Trial ID
NCT04668196
Start Date
May 22 2020
End Date
January 25 2021
Last Update
April 13 2021
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain, 08916
2
Hospital General de Granollers
Granollers, Barcelona, Spain, 08402
3
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
4
Fundació Althaia
Manresa, Barcelona, Spain, 08243